GSK has applied to the FDA for approval. The drug had been given "fast track" status by the FDA which guarantees an answer within 6 months. So it may be approved by March 2007.
Regards
Joe
__________________
A Proud webmaster to the internet's most informed, educated, COMPASSIONATE and caring group of breast cancer survivors.
Illegitimi non carborundum
My Album
|